The genes with the most frequent SGMs associated with the three mutational processes are clearly enriched in core TSGs, including early oncogenic drivers such as APC, later drivers of tumor progression and metastasis such as CDH1, as well as less-characterized cancer genes such as EPHA2 and MGA. The gene discussed is EPHA2; the disease is cancer.